The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine

Clinical and Experimental Hypertension

Volumn 30, Issue 7, 2008, Pages 640-647

  Niizuma, Shinichiro ^a   Nakahama, Hajime ^a   Kamide, Kei ^a,b   Fukuchi, Kazuki ^a   Iwanaga, Yoshitaka ^a   Nakata, Hiroto ^a   Yoshihara, Fumiki ^a   Horio, Takeshi ^a   Nakamura, Satoko ^a   Kawano, Yuhei ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b Division of Hypertension and Nephrology   (Japan)

Author keywords

Aldosterone to renin ratio; Diagnosis; Primary aldosteronism

Indexed keywords

ALDOSTERONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; RENIN; SPIRONOLACTONE;

ACCURACY; ADRENAL CORTEX ADENOMA; ADRENAL HYPERPLASIA; ADRENAL SCINTISCANNING; ADULT; ALDOSTERONE BLOOD LEVEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYPERTENSION; JAPAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; PROSPECTIVE STUDY; QUANTITATIVE ASSAY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SENSITIVITY AND SPECIFICITY;

ADENOMA; ADRENAL GLAND NEOPLASMS; ADRENAL HYPERPLASIA, CONGENITAL; AGED; ALDOSTERONE; ANTIHYPERTENSIVE AGENTS; DRUG RESISTANCE; FEMALE; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; JAPAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENIN;

EID: 54049158074     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960802443282     Document Type: Article

References (11)

1. Omura M, Saito J, Yamaguchi K, Kakuta Y, Nishikawa T. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens Res. 2004;27:193-202.
2. Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48:2293-2300.
3. Mattsson C, Young WF Jr. Primary aldosteronism: Diagnostic and treatment strategies. Nat Clin Pract Nephrol. 2006;2:191, 198-208, 230.
4. Ganguly A. Primary aldosteronism. N Engl J Med. 1998;339:1828-1834.
5. Mulatero PMF, Veglio F, Rabbia F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension. 2002;40:897-902.
6. Seifarth C, Trenkel S, Schobel H, Hahn EG, Hensen J. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism. Clin Endocrinol (Oxf). 2002;57:457-465.
7. Mulatero P, Bertello C, Garrone C, Rossato D, Mengozzi G, Verhovez A, Fallo F, Veglio F. Captopril test can give misleading results in patients with suspect primary aldosteronism. Hypertension. 2007;50:e26-e27.
8. Nakahama H, Fukuchi K, Yoshihara F, Nakamura S, Inenaga T, Takiuchi S, Kamide K, Horio T, Kawano Y. Efficacy of screening for primary aldosteronism by adrenocortical scintigraphy without discontinuing antihypertensive medication. Am J Hypertens. 2003;16:725-728.
9. Gallay BJAS, Xu L, Toivola B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: Plasma aldosterone-renin ratio. Am J Kidney Dis. 2001;37:699-705.
10. Munakata M. [Primary aldosteronism.] Nippon Rinsho. 2000;58 (Suppl. 2):534-537.
11. Kaplan NM. Primary aldosteronism. In: Clinical Hypertension. 8th ed. Baltimore, Md.: Williams & Wilkins, 2002;455-479.